l-carnitine in the treatment of type ii diabetes The carnitine system and cancer
Description
doi: 10.1111/j.1365-2036.2011.04685.x

The gut microbiota converts L-carnitine into trimethylamine (TMA), which may then be oxidized by enzymes in the liver to form trimethylamine N-oxide (TMAO)

Lower the dose Less substrate usually means less TMA formation
:max_bytes(150000):strip_icc()/GettyImages-1299286851-18ab6e02931940ad963dda93851b6dc7.jpg)
References 1 AdhavN

Another explanation for the protective benefits of probiotic and prebiotic treatments on CVD is host immune system regulation
